General information

Announcements(0)

Overview

Manual for Online Meeting

Participant Registration

Abstract Submission (Oral/Poster Presentation)

General information 2

Abstract Submission (Late-Breaking Session)

Program

Sessions

Search presentations

pharm141_en.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

A password that applicants have been notified of is required to view abstracts.<br>If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.<br>We will reply after confirming that you were a participant.<br>Thank you for your understanding.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Timetable

Application and advancement of artificial intelligence for drug development

The pharmaceutical research and drug development can be roughly divided into two fields: drug discovery and pharmaceutical technology innovation. In the field of drug discovery, machine learning has been used in the past to study quantitative structure-activity relationships, and more recently, artificial intelligence (AI) has been used to predict drug-target-molecule interactions, efficacy, safety, drug repositioning, and ADMET. In the field of pharmaceutical technology innovation, the design of optimal dosage forms and the development of new DDS have been considered by using AI. In addition, it is necessary that individual researchers and developers become more literate in AI. From this backdrop, we have planned four symposia in this symposium with the aim of understanding the current status and future development of the use of AI in both fields. Dr. Arima presents “Machine learning and deep learning for drug discovery and pharmaceutical technology innovation”, Dr. Yamanishi gives a talk on “Data-driven drug discovery using machine learning”, Dr. Sekijima introduces “Application and sophistication of artificial intelligence in new drug research and development”, and Dr. Sese describes “Artificial intelligence technology that should be used by the members of the Pharmaceutical Society of Japan who are focused on experiments”. We hope that this symposium will be of assistance to the participants in the pharmaceutical research and drug development. 

Use of artificial intelligence in drug discovery and pharmaceutical technology innovation

The 141st Annual Meeting of the Pharmaceutical Society of Japan (Hiroshima)

Presentation Information

[S12-3]Application and advancement of artificial intelligence for drug development

Password required to view